Permission summary

Permission ID
DL000300046
Issue date
Expiry date
Status
Active
Activity site

218-220 Hammond Road Dandenong South 3175

Permission holder

MED-X PTY LTD
Level 4, Suite 2
210 Kings Way
SOUTH MELBOURNE VIC 3205
AU

Activity

View a list of all activities EPA regulates.
A01 (Reportable priority waste management)
Issued

More permission details

  • Conditions

    Learn more about permission conditions.

    DL_C01
    Commissioning activities must be undertaken in accordance with the commissioning plan approved by the Authority.
    DL_C02
    You must immediately notify the Authority by calling 1300 EPA VIC (1300 372 842) in the event of: a) A discharge, emission or deposit which gives rise to, or may give rise to, actual or potential harm to human health or the environment; b) A malfunction, breakdown or failure of risk control measures at the site which could reasonably be expected to give rise to actual or potential harm to human health or the environment; or c) Any breach of the licence.
    DL_C03
    Commissioning must not cause or result in any breach of any permission issued by the Authority for the permission activity, except where authorised by a condition of this licence.
    DL_C05
    1. You must develop a risk management and monitoring program for your activities which: (a) identifies all the risks of harm to human health and the environment which may arise from the activities you are engaging in at your activity site; (b) clearly defines your environmental performance objectives; (c) clearly defines your risk control performance objectives; (d) describes how the environmental and risk control performance objectives are being achieved; (e) identifies and describes how you will continue to eliminate or minimise the risks in 1(a) (above) so far as reasonably practicable; and (f) describes how the information collated in compliance with this clause, is or will be disseminated, used or otherwise considered by you or any other entity. 2. The risk management and monitoring program must be: (a) documented in writing; (b) signed by a duly authorised officer of the licensed entity (c) made available to the Authority on request.
    DL_C06
    Within 30 days days of the expiry of this permission, you must provide to EPA a report detailing the results of the commissioning monitoring program.
    DL_C07
    Within 30 days of the completion of the approved activities, you must provide to EPA a written report that summarises the activities undertaken and includes: (a) A report with the testing results and assessment of the autoclave technology; (b) Duration of the activity to determine the efficacy of the commissioning trial; (c) Evidence of L200-H being transported to a lawful place; and (d) Evidence of adoption of all recommendations identified in Appendix E– Fire Risk Assessment # 274648-00 dated 18/05/2023.
    DL_C10
    You must ensure that: a) Only waste of a type shown in Appendix 4 of this approval is accepted at the activity site; and b) If it is identified that any waste has been received at the activity site that is of a type not shown in Appendix 4 in contravention of paragraph a) above, such waste must be placed in a designated and sign-posted temporary storage area and sent for disposal to a site authorised by the Authority to receive such waste within 21 days of the date it was received.
    DL_G01
    A copy of this licence must be kept at the site and be easily accessible to persons who are engaging in an activity conducted at the site. Information regarding the requirements of the licence and the Act duties must be included in site induction and training information.
    DL_G02
    The development of the proposed medical and quarantine waste treatment facility, including the installation of autoclave and associated equipment for the decontamination of medical and quarantine waste at 218-220 Hammond Road must be conducted in accordance with the listed approved plans and documents: Initial application documents, submitted on 23/05/2023 (a) APP026013- Application Details.pdf (b) APP026013- Invoice.pdf (c) Appendix A- Redacted.pdf (d) Appendix A.pdf- Med-X Pty Ltd ASIC Company Extract and Declarations • F1017 Fit and proper person questionnaire • F1018 Prohibited person questionnaire • Process Flow Diagram (e) Appendix B.pdf- Site Layout Plans and Drawings Site Activity Plan (f) Appendix C.pdf- • Integrated Management Systems, Med-X Boiler Operations • Integrated Management Systems, Med-X Autoclave Operations • Integrated Management Systems, Med-X Shredder Operations (g) Appendix D.pdf- Med-X Hammond Rd Risk Assessment- Stage 2 (h) Appendix E.pdf- Fire Risk Assessment (i) Appendix F.pdf- Air Quality and Odour Assessment (j) Appendix G.pdf- Noise Risk Assessment (k) Appendix H.pdf- Letter to the Neighbour (l) Appendix I.pdf- Parking Impact Assessment Report (m) Appendix J.pdf- Emergency & Incident Response Management Plan (n) Appendix K.pdf- • Integrated Management Systems, Med-X Control Management • Integrated Management Systems, Med-X Handling Clinical and Quarantine Waste • Integrated Management Systems, Med-X Handling Cytotoxic, Anatomical and Pharmaceutical Waste • Integrated Management Systems, Med-X Weighing Waste • Integrated Management Systems, Med-X Cleaning Procedure • Integrated Management Systems, Med-X Autoclave Efficacy Testing Procedure • Integrated Management Systems, Med-X WHS Incident and Hazard Reporting Procedure • Integrated Management Systems, Med-X Spill Control Management • Med-X Healthcare Solutions IMS Procedure, Incident Investigation • Integrated Management Systems, Med-X Cleaning Procedure • Med-X Integrated Management System Manual • Safety Management System, WHS Incident and Hazard Reporting Procedure • Med-X Healthcare Solutions IMS Procedure, Competence & Awareness • Microbial Efficacy Report of the Bondtech Autoclave Model BTT5’X 15’ (o) Appendix L.pdf- Clinical Waste Audit (p) Med-X- F1017.pdf (q) Med-X- F1018.pdf (r) Med-X (Medical Waste Facility) - Development Licence Application.pdf. In the event of any inconsistency between the approved documents and the conditions of this permission, the conditions of this permission shall prevail.
    DL_G03
    Subject to the following conditions, this development licence allows you to: in accordance with your application (APP026013) and supporting information, construct a medical and quarantine waste treatment facility that includes: (a) Installation of one medical waste autoclave (a total capacity of 450 kg per cycle), steam boiler, boiler flue and safety relief vents (from autoclave), Shredder and compactor, triple interceptor tank 1000 L, trade waste sumps, connecting pipework, 1000L triple interceptor pit, and valve pit (including flow meter), bunding and drainage (to trade waste), storage racking and general wash bay, an additional storage container and refrigeration container, alterations to internal and external loading arrangements, firefly detection and suppression system, and magnetic flow meter; and (b) Temporary storage of 6.23 tonnes of R100, 0.29 tonnes of R120 & R140, 0.19 tonnes of R130, 250 Litres of L200-H, and 0.06 tonnes sanitary waste at the activity site at any time.
    DL_G04
    This permission does not take effect until a copy of any planning permit or amendment to a planning scheme required under the Planning and Environment Act 1987 (Vic) and related planning schemes has been provided to the Authority by the applicant.
    DL_G05
    This permission expires: (a) on the issue or amendment of an operating licence or permit relating to all activities covered by this permission; (b) when the Authority advises in writing that all activities covered by this permission have been satisfactorily completed and the issue or amendment of an operating licence or permit is not required; or c) on the expiry date listed on the front page of this permission.
    DL_G06.02
    You must: (a) provide the Authority with a financial assurance in a form and for an amount determined by the Authority, by a date specified by the Authority; and (b) maintain such financial assurance (including any part of such assurance) so that it can be claimed on, utilised or realised by the Authority as and when required.
    DL_G07
    You must: (a) develop and maintain a decommissioning plan that is in accordance with the current decommissioning guidelines published by the Authority; (b) provide the decommissioning plan to the Authority upon request; (c) supply to the Authority an updated detailed decommissioning plan 45 business days prior to commencement of decommissioning, if you propose to divest a section of the licensed site, cease part or all of the licensed activity or reduce the basis upon which the licence was granted to a point where licensing is no longer required; and (d) decommission the licensed site in accordance with the detailed decommissioning plan, to the satisfaction of the Authority and within any reasonable timeframe which may be specified by the Authority.
    DL_R01
    At least 30 business days before the commencement of any commissioning, you must provide to the Authority report/reports that include(s): (a) Commissioning Trial Plan that includes (but is not limited to): i. Proof of performance testing of the autoclave technology to demonstrate the inactivation of any microbes and pathogens present within the waste and successful decontamination of the waste to achieve a six-log reduction in G. stearothermophilus spores as set out in the application. ii. Evidence of all four autoclave waste carts being tested with an indicator during each run. iii. Evidence of runs conducted with the chosen parameters to achieve a six-log reduction in G. stearothermophilus spores with every autoclave run. iv. Conduct biological testing periodically (weekly) demonstrating a six-log reduction in G. stearothermophilus spores and the observations/results being recorded. v. An odour monitoring/ verification program to confirm that the proposed facility does not have any odour emissions that require retrospective control mitigation measures to be installed. (b) Evidence of implementation of electronic inventory management system that keeps track of incoming wastes, and waste held at the site at any one time. (c) You must submit the Risk Management and Monitoring Plan per condition DL_C05 to include, but not be limited to the following: i. Record of all staffs handing autoclave being well-trained in operating the equipment. ii. Ensure the autoclave carts are regularly cleaned. iii. Conduct autoclave validation once every six (6) months with a maximum load and minimum load configuration. iv. Evidence of Med-X educating waste generators on proper waste segregation. v. Contingency Plan that includes details of the measures to be implemented during commissioning for the storage and treatment of biohazardous waste in the event of unexpected issues during commissioning affecting the processing of those wastes.
    DL_R02
    You must not commence commissioning of the operating components of the development activities until you have received the Authority's written approval of the of the report(s)/plan(s) which is required pursuant to condition(s) DL_R01 and DL_C05.
    DL_R04
    At least 30 business days before the commencement of any construction, you must provide to the Authority documentation that include(s): (a) Final detail design showing: i. Fire mitigation control measures/system. ii. Installation of bunding in accordance with EPA Guidelines 1698: Liquid storage and handling guidelines. iii. General washing bay. iv. Wastewater collection and drainage system inside the building, including trade waste sump, connecting pipework, 1000 triple interceptor pit and valve pit and general washing bay. The design must demonstrate that process wastewater will be fully contained and discharged to sewer with no leakage flowing into external stormwater drains. v. Any changes to the proposed layout or operation of the equipment (within the bounds of the EPA permission. vi. The capacity and location of the secure refrigeration unit for refrigeration of R100 (Anatomical) wastes. (b) A Construction Environment Management Plan (CEMP) in accordance with EPA requirements - 1834: Civil construction, building and demolition guide (EPA Publication). (c) A report a qualitative risk analysis/assessment, risk matrix and risk ranking for Appendix E – Fire Risk Assessment as per your application.
    DL_W02
    You must notify the Authority in writing when the development activity authorised by this permission has commenced.
    DL_W03
    You must notify the Authority when the construction associated with the development activities covered by this approval has been completed.
    DL_W04
    You must not commission or use the operating components of the development activities without the written approval of the Authority.
    DL_W08
    You must install (a) The autoclave technology, associated Programmable Logic Controller (PLC) and treatment equipment and demonstrate to the EPA that all necessary alarms and controls are functioning such that the technologies and facility will be able to operate as per the design and required microbial decontamination levels; (b) Suitable bunding around the liquid storage as per EPA Guidelines 1698: Liquid storage and handling guidelines, per the condition DL_R04.
    DL_W10
    You must implement all liquid storage containment and handling measures in accordance with “Liquid storage and handling guidelines” (EPA Publication 1698, released June 2018).

  • Waste information

    Learn more about waste acceptance regulations.

    L200-H
    Industrial wastewater (excluding sewage) not otherwise specified in "Schedule 5—Waste Classification" of the Environment Protection Regulations 2021
    R100
    Clinical and related wastes, including biomedical waste, not otherwise specified in items 97, 98 or 99 of "Schedule 5—Waste Classification" of the Environment Protection Regulations 2021
    R120
    Waste from the use of pharmaceutical products, not otherwise specified in items 96, 98 or 99 of "Schedule 5—Waste Classification" of the Environment Protection Regulations 2021
    R130
    Cytotoxic substances
    R140
    Waste from the production of pharmaceutical products and cosmetics, not otherwise specified in items 96, 97 or 98 of "Schedule 5—Waste Classification" of the Environment Protection Regulations 2021

  • Documents

    In the event of a discrepancy between the conditions listed on this page and the linked statutory document, the statutory document prevails

    DL000300046 - Statutory Document.pdf

  • Performance Statements

    There are no performance statements